In this special episode recorded live at the Massachusetts Prostate Cancer Coalition Symposium, host Jordan Rich welcomes Dr. Howard Soule, Chief Science Officer Emeritus of the Prostate Cancer Foundation, and Dr. Adam Feldman, Director of Urologic Research at Massachusetts General Hospital, for a wide-ranging conversation about the future of prostate cancer research.

Howard R. Soule, Ph.D., Chief Science Officer Emeritus and executive leader of the Prostate Cancer Foundation (PCF) for the past three decades. At PCF he coordinated global academic, government and biopharmaceutical sector research activity and was responsible for the implementation of Prostate Cancer Foundation global research strategies. Dr. Soule is also a member of the Department of Defense Prostate Cancer Research Program Integration Panel. In addition, he is a Senior Fellow of the Milken Institute, a non-partisan economic think tank and parent organization to FasterCures.

Adam Feldman, M.D. M.P.H., is a urologist at the Massachusetts General Hospital Department of Urology. He specializes in the treatment of cancer and related research. Dr. Feldman is a faculty member and Urologic Oncologist in the Department of Urology at Massachusetts General Hospital and is Director of the Combined Harvard Urologic Oncology Fellowship.